Form 4: Hims & Hers Health CEO Andrew Dudum Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on September 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Andrew Dudum, CEO of Hims & Hers Health, Inc., sold shares of Class A Common Stock on September 20, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on November 29, 2023.
- A total of 42,099 shares were sold at an average price of $16.2922, with prices ranging from $15.765 to $16.74.
- An additional 3,668 shares were sold at an average price of $16.7798, with prices ranging from $16.76 to $16.815.
- Following the transactions, Dudum directly owns 70,683 shares.
- Dudum also indirectly owns shares through various trusts, including AD 2022 GRAT 3, Andrew Dudum 2015 Trust, AD 2021 GRAT, Dudum Family Community Property Trust, AD 2021 GRAT 2, AD 2023 GRAT, AD 2022 GRAT 2, Richard M. Dudum Irrevocable 1 U/A, and Dudum Family Heritage Trust UAD.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 10/15/1997 | Date of Richard M. Dudum Irrevocable 1 U/A |
| 07/02/2015 | Date of Andrew Dudum 2015 Trust |
| 11/01/2021 | Date of AD 2021 GRAT and AD 2021 GRAT 2 |
| 08/10/2021 | Date of Dudum Family Heritage Trust UAD |
| 09/07/2022 | Date of AD 2022 GRAT 2 |
| 11/28/2022 | Date of AD 2022 GRAT 3 |
| 09/05/2023 | Date of AD 2023 GRAT |
| 11/29/2023 | Date the Rule 10b5-1 trading plan was adopted |
| 09/20/2024 | Date of stock sale transactions |
| 09/23/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.